Skye Biologics has been added to Academy Medical’s DAPA contract

Academy Medical is pleased to announce their partner, Skye Biologics has been added to Academy Medical’s DAPA contract. Skye Biologics develops and manufactures BioECM® products designed to assist the body in its natural ability to remodel properly. These products are formulated to protect and augment degenerated or damaged tissues in surgical repairs and non-operative therapy as a potential alternative to surgery. Their strategic partnership with Academy Medical helps provide clinicians with advanced wound care technologies. For years, Academy Medical has been working with both government procurement agencies and medical/surgical manufacturers to help simplify the contracting process and provide more sales channels to the manufacturers. Academy Medical’s efforts can help manufacturers gain access to government contracts faster than they would by themselves – resulting in new and innovative therapies available sooner.